for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Mochida Pharmaceutical Co., Ltd.

4534.T

Latest Trade

4,475.00JPY

Change

-40.00(-0.89%)

Volume

51,800

Today's Range

4,445.00

 - 

4,540.00

52 Week Range

3,940.00

 - 

6,110.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
4,515.00
Open
4,540.00
Volume
51,800
3M AVG Volume
1.14
Today's High
4,540.00
Today's Low
4,445.00
52 Week High
6,110.00
52 Week Low
3,940.00
Shares Out (MIL)
39.23
Market Cap (MIL)
183,444.50
Forward P/E
26.05
Dividend (Yield %)
1.88

Next Event

Q3 2020 Mochida Pharmaceutical Co Ltd Earnings Release

Latest Developments

More

Idorsia And Mochida Enter Into License Agreement

Mochida Pharmaceutical Co Completes Share Repurchase

Mochida Pharmaceutical Co Ltd Says To Buy Back Up To 1.26 Percent Of Own Shares Worth 2.5 Billion Yen Through March 22

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Mochida Pharmaceutical Co., Ltd.

Mochida Pharmaceutical Co., Ltd. is a Japan-based company, principally engaged in the production and sale of drugs. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products, the purchase and sale of raw materials, brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses, damage insurance agency business, as well as the publishing of medicine-related books and the production of print. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.

Industry

Biotechnology & Drugs

Contact Info

1-7, Yotsuya

+81.3.33587211

http://www.mochida.co.jp

Executive Leadership

Naoyuki Mochida

President, Representative Director

Chu Sakata

Senior Managing Director, Senior Managing Executive Officer, Representative Director

Keiichi Sagisaka

Senior Managing Executive Officer, Director

Yoichi Kono

Managing Executive Officer, Director

Kiyoshi Mizuguchi

Managing Executive Officer, Director

Key Stats

Revenue (MM, JPY)

2017

0.1K

2018

0.1K

2019

0.1K

2020(E)

0.1K
EPS (JPY)

2017

214.730

2018

227.275

2019

212.870

2020(E)

173.300
Price To Earnings (TTM)
29.22
Price To Sales (TTM)
1.77
Price To Book (MRQ)
1.41
Price To Cash Flow (TTM)
20.45
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
4.61
Return on Equity (TTM)
3.87

Latest News

Latest News

BRIEF- Mochida Pharmaceutical to retire treasury shares

* Says it will retire 200,000 shares (0.97 percent of outstanding) of its common stock on March 23

BRIEF-Mochida Pharmaceutical signs contract for joint development of sale of gout and hyperuricemia treatment FYU-981 in Japan with FUJIYAKUHIN Co., Ltd.

* Says it signed a contract for joint development of sale of gout and hyperuricemia treatment FYU-981 in Japan with FUJIYAKUHIN Co., Ltd.

BRIEF-Mochida Pharmaceutical to retire 465,000 treasury shares

* Says it will retire 465,000 shares (2.2 percent stake) of its common stock on March 23

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up